Omeros Corp. Stock
Price
Target price
€2.86
€2.86
1.350%
0.038
1.350%
-
22.04.24 / Frankfurt
WKN: A0NBFF / Symbol: OMER / Name: Omeros / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
Omeros Corp. Stock
There is an upward development for Omeros Corp. compared to yesterday, with an increase of €0.038 (1.350%).
Our community identified positive and negative aspects for Omeros Corp. stock for the coming years. 3 users see the criterium "Worthwhile Investment for the next years" as a plus for the Omeros Corp. stock. On the other hand our users think that "Non-cyclic/Cyclic" could be a problem in the future.
Pros and Cons of Omeros Corp. in the next few years
Pros
?
S********** s********
?
G***** c******* t* c**********
?
B****
Cons
?
W********* I********* f** t** n*** y****
?
M***** P*******
?
C******** o* t** e**********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of Omeros Corp. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| Omeros Corp. | 1.350% | -10.121% | -9.371% | -45.377% | -9.892% | -81.098% | -82.705% |
| Ardelyx Inc. | -1.110% | -4.466% | -13.831% | 35.956% | 5.848% | -10.686% | - |
| Salarius Pharmaceuticals Inc. | 0.950% | -2.778% | -19.231% | -68.421% | -24.324% | -98.250% | -99.994% |
| Brainstorm Cell | -4.690% | -0.586% | 0.792% | -81.287% | 119.397% | -80.271% | - |
Comments
Omeros Co. (NASDAQ: OMER) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for OMER provided by MarketBeat
Omeros Co. (NASDAQ: OMER) was downgraded by analysts at StockNews.com from a "hold" rating to a "sell" rating.
Show more
Ratings data for OMER provided by MarketBeat
Omeros Co. (NASDAQ: OMER) is now covered by analysts at StockNews.com. They set a "sell" rating on the stock.
Show more
Ratings data for OMER provided by MarketBeat